Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$8.33 - $13.79 $3.64 Million - $6.02 Million
-436,700 Closed
0 $0
Q1 2020

Feb 12, 2021

BUY
$3.83 - $8.79 $1.66 Million - $3.8 Million
432,333 Added 9900.0%
436,700 $3.84 Million
Q1 2020

May 15, 2020

BUY
$3.83 - $8.79 $16,086 - $36,918
4,200 Added 2514.97%
4,367 $11,000
Q4 2019

Feb 14, 2020

BUY
$3.36 - $4.81 $100 - $144
30 Added 21.9%
167 $0
Q2 2019

Aug 14, 2019

BUY
$4.93 - $8.8 $675 - $1,205
137 New
137 $3,000
Q2 2018

Aug 14, 2018

SELL
$13.3 - $17.49 $199,500 - $262,350
-15,000 Closed
0 $0
Q1 2018

Feb 11, 2021

BUY
$12.26 - $18.98 $182,061 - $281,853
14,850 Added 9900.0%
15,000 $237,000
Q1 2018

May 14, 2018

BUY
$12.26 - $18.98 $1,839 - $2,847
150 New
150 $0

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About Kala Pharmaceuticals, Inc.


  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $7.69M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.